Skip to main content
. 2016 Feb 12;7(1):e00100-16. doi: 10.1128/mBio.00100-16

FIG 1 .

FIG 1 

Schematic description of study design. (A) Timeline of clinical evaluation and PBMC sampling. (B) Flowchart of the number of patients with resolved illness or persistent symptoms. Abbreviations: non-PTLDS, post-treatment Lyme disease symptoms and no functional decline; PTLDS, PTLDS with a functional decline.